NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DE-16-007 from the NIH Guide for Grants and Contracts
Notice NOT-DE-16-008 from the NIH Guide for Grants and Contracts
Notice NOT-DK-16-029 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-18-011 from the NIH Guide for Grants and Contracts. This FOA invites applications for institutional research career development (K12) programs from applicant organizations that propose to support a program of mentored institutional career development programs for junior faculty investigators who have recently completed postgraduate clinical training in a subspecialty area of Pediatrics, and are committed to launching an independent research career. The program provides supervised research training to assist the transition into productive physician scientists.
Funding Opportunity PA-17-055 from the NIH Guide for Grants and Contracts. The National Institutes of Environmental Health Sciences hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) with R01, R21, R15, R35, R37, or P01 awards that funds are available for administrative supplements to support summer research experiences in environmental health science for high school students, college undergraduates, masters degree candidates, medical students, secondary school science teachers, and science professors from R15/AREA grant eligible institutions. Administrative supplements must support work within the scope of the original project.
Funding Opportunity RFA-DK-16-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to establish a multi-disciplinary group of investigators to be known as the APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO) Scientific Data Research Center (SDRC), and runs in parallel with a separate FOA that invites applications for the APOLLO Clinical Centers (CCs) (RFA-DK-16-025). The APOLLO Network consortium will design and conduct studies of a comprehensive, prospective longitudinal cohort to determine the impact of APOL1 genetic variants as susceptibility factors in US kidney transplant recipients who received kidneys from African-American donors. In addition, the consortium will follow the course of African-American kidney donors. Primary outcomes are the rate of change of kidney function in recipients, and rates of acute rejection of the kidney transplant, graft failure, and return to maintenance dialysis rates in the recipients. Outcomes in donors, including vital and renal functional status, will be assessed to the greatest extent possible.
Funding Opportunity RFA-DK-16-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to establish a multi-center, multi-disciplinary group of investigators to be known as the APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO). This FOA invites applications for the APOLLO Network Clinical Centers (CCs) and runs in parallel with a separate FOA that invites applications for the APOLLO Network Scientific Data Research Center (SDRC) (RFA-DK-16-024). The APOLLO Network will design and conduct studies of a prospective longitudinal cohort to determine the impact of APOL1 genetic variants as susceptibility factors in US kidney transplant recipients who received kidneys from African American donors. In addition, the consortium will follow the course of African American kidney donors. Primary outcomes are the rate of change of kidney function in recipients, and rates of acute rejection of the kidney transplant, graft failure, and return to maintenance dialysis rates in the recipients. Outcomes, including vital and renal functional status, in donors will be assessed to the greatest extent possible.
Funding Opportunity PAR-17-054 from the NIH Guide for Grants and Contracts. This FOA invites applications that will combine multiple cohorts in order to improve statistical power and clarify risk and protective factors for Alzheimers disease and related dementias (AD/ADRD).
Funding Opportunity RFA-AI-16-081 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on developing and utilizing novel predictive assays, models and/or research tools based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa.
Notice NOT-DE-17-002 from the NIH Guide for Grants and Contracts
Notice NOT-HL-16-464 from the NIH Guide for Grants and Contracts
Notice NOT-HD-16-034 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-001 from the NIH Guide for Grants and Contracts
Notice NOT-GM-16-118 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-16-080 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to establish Systems Biology Centers that use systems biology approaches to build predictive models for infectious diseases. These models will be derived from hypotheses related to systems-level host/pathogen molecular interactions during infection or treatment using integrated datasets generated from a combination of high-throughput experimental approaches, including omics technologies and computational approaches. Importantly, the Centers must clearly integrate experimental approaches and computational modeling to test and validate hypotheses of significance to the infectious diseases field.
Funding Opportunity RFA-AG-17-054 from the NIH Guide for Grants and Contracts. This funding opportunity invites applications that would enhance the goals and deliverables of the AMP-AD Target Discovery and Preclinical Validation and M2OVE Consortia by maximizing the usability of the data and analytical results generated by these programs, seizing opportunities for additional target and biomarker discovery, and accelerating the validation of the novel targets and biomarkers being discovered within the AMP-AD and M2OVE-AD Consortia.
Notice NOT-OD-17-020 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-019 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-018 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-017 from the NIH Guide for Grants and Contracts